Market Place
Sourcing Support
Tubulis Receives FDA Fast Track for TUB-040 in Ovarian Cancer
27 Jun 2024 //
BUSINESSWIRE
Aravive Receives Third Development Milestone from 3D Medicines
10 Oct 2022 //
GLOBENEWSWIRE
Junshi Biosciences Receives NMPA Approval of sNDA for Toripalimab in Combination
20 Sep 2022 //
GLOBENEWSWIRE
Motto International Corp. Issues Voluntary Recall of Bull Platinum
19 Dec 2019 //
FDA
Merck Receives Positive EU CHMP Opinion for Two New Regimens of KEYTRUDA®
19 Oct 2019 //
BIOSPACE
AstraZeneca’s Imfinzi tees up lung cancer fight with Roche
28 Jun 2019 //
FIERCE PHARMA
ImmunoGen cuts deep to eke out cash for mirvetuximab trial
27 Jun 2019 //
FIERCE BIOTECH
Merck`s Keytruda gives BMS` Opdivo some company with small cell lung cancer nod
19 Jun 2019 //
FIERCE PHARMA
MET inhibitors from Incyte/Novartis and Germany`s Merck face off
05 Jun 2019 //
ENDPTS
Shrinking 60% of lung cancers, Blueprint`s RET drug poised for 2020 filing
04 Jun 2019 //
FIERCE BIOTECH
Astellas, Seattle Genetics` ADC banishes 12% of bladder cancers
03 Jun 2019 //
FIERCE BIOTECH
What to watch for, including Keytruda, Lynparza, KRAS and more
31 May 2019 //
FIERCE PHARMA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.